DPP-4 Inhibitors Type: Oral medications for Type 2 Diabetes Action: Boost insulin release, lower glucagon levels in a glucose-dependent manner Risk: Minimal hypoglycemia, no significant weight gain Examples: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin
